Despite clinical evidence of poor oral health and hygiene in Parkinson's disease (PD)
patients, the mouth is often overlooked by both patients and the medical community, who …

Given the aging population with increasing morbidity but also importantly scientific and
technological advances that prolong the ability to support survival in intensive care, the …

Background and purpose Hypomimia is a prominent clinical feature in people with
Parkinson's disease (PD), but it remains under‐investigated. We aimed to examine the …

Movement disorders are neurological conditions characterized by involuntary motor
movements, such as dystonia, ataxia, chorea myoclonus, tremors, Huntington's disease …

Abstract Motor Neuron Disease (MND) is a progressive and largely fatal neurodegeneritve
disorder with a lifetime risk of approximately 1 in 300. At diagnosis, up to 25% of people with …

Sialorrhea, or excessive saliva beyond the margin of the lip, is a common problem in many
neurological diseases. Previously, sialorrhea has been underrecognized in Parkinson's …

Background and Objectives To investigate the efficacy and safety of repeated injections of
incobotulinumtoxinA (incoBoNT/A) for treatment of chronic sialorrhea (drooling) associated …

In the present study, we investigated the anti-Parkinson's effect of vanillic acid (VA)(12
mg/kg, 25 mg/kg, 50 mg/kg po) against rotenone (2 mg/kg sc) induced Parkinson's disease …

Parkinson's disease (PD) is generally considered as a primary movement disorder, but the
majority of patients also suffer from non-motor oral, salivary symptoms. The most common …

Background Drooling is a clinically relevant non-motor symptom of people with Parkinson's
disease (PwP). Several drooling rating scales are available. Nevertheless, the compelling …